These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25237319)

  • 1. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.
    Farshchian F; Ramezani Tehrani F; Amirrasouli H; Rahimi Pour H; Hedayati M; Kazerouni F; Soltani A
    Int J Endocrinol Metab; 2014 Jul; 12(3):e15503. PubMed ID: 25237319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
    Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
    Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Serum Visfatin Level in Non-obese Women with Polycystic Ovary Syndrome and Matched Control.
    Ali AI; Nori W
    Reprod Sci; 2022 Nov; 29(11):3285-3293. PubMed ID: 35687303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls.
    Kim JJ; Choi YM; Hong MA; Kim MJ; Chae SJ; Kim SM; Hwang KR; Yoon SH; Ku SY; Suh CS; Kim SH
    Obstet Gynecol Sci; 2018 Mar; 61(2):253-260. PubMed ID: 29564317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Pangaribuan B; Yusuf I; Mansyur M; Wijaya A
    Ther Adv Endocrinol Metab; 2011 Dec; 2(6):235-45. PubMed ID: 23148188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome.
    Tarkun I; Dikmen E; Cetinarslan B; Cantürk Z
    Eur Cytokine Netw; 2010 Dec; 21(4):272-7. PubMed ID: 21126943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.
    Abdul-Maksoud RS; Zidan HE; Saleh HS; Amer SA
    Genet Test Mol Biomarkers; 2020 Jul; 24(7):409-419. PubMed ID: 32460545
    [No Abstract]   [Full Text] [Related]  

  • 14. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Demirci H; Oztürk C; Kan E; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2009 Apr; 25(4):246-52. PubMed ID: 19408174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin and adiponectin - markers in women with polycystic ovarian syndrome.
    Bannigida DM; Nayak SB; R V
    Arch Physiol Biochem; 2020 Oct; 126(4):283-286. PubMed ID: 30318936
    [No Abstract]   [Full Text] [Related]  

  • 17. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.
    Lajunen TK; Purhonen AK; Haapea M; Ruokonen A; Puukka K; Hartikainen AL; Savolainen MJ; Morin-Papunen L; Tapanainen JS; Franks S; Järvelin MR; Herzig KH
    Eur J Clin Invest; 2012 Mar; 42(3):321-8. PubMed ID: 21913913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Correlation Analysis between Polycystic Ovary Syndrome (PCOS) and Serum Visfatin Levels in Middle-Aged Women: Systematic Review and Meta-Analysis.
    Chen J; Hu L; Ling Y; Xu Y; Yu X; Ma L; Shou M
    Discov Med; 2023 Apr; 35(175):168-177. PubMed ID: 37105926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study.
    Gümüş Ü; Güzel AI; Topcu HO; Timur H; Yılmaz N; Danışman N
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):249-53. PubMed ID: 26049941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.